PERIHILAR CHOLANGIOCARCINOMA
Clinical trials for PERIHILAR CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PERIHILAR CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for PERIHILAR CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bile duct cancer trial halted after just one patient
Disease control TerminatedThis phase II trial tested a combination of chemotherapy infused directly into the liver (HAIC) plus two immunotherapy drugs (atezolizumab and bevacizumab) given before and after surgery for high-risk bile duct cancer. The goal was to see if this approach could shrink tumors and …
Matched conditions: PERIHILAR CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Cancer combo trial halted early: what we know
Disease control TerminatedThis phase 2 trial tested two drugs—ulixertinib and hydroxychloroquine—in 47 people with advanced gastrointestinal cancers that have certain genetic mutations (MAPK pathway). The goal was to see if the combination could shrink tumors. However, the study was terminated early, so t…
Matched conditions: PERIHILAR CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: BioMed Valley Discoveries, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC